SUMMA SEMICONDUCTOR OY

Their core work

Summa Semiconductor is a Finnish deep-tech SME based in Espoo specialising in semiconductor and photonic device technologies. Their work spans from flexible microchip manufacturing processes to integrated photonic systems for biological sensing applications. In practice, they develop the physical components — chips, photonic structures, fibre-optic sensors — that underpin biosensing and optical measurement instruments. Their participation in MSCA-RISE network IPN-Bio alongside a prior SME Phase 1 grant suggests they sit at the product-development end of the R&D spectrum: translating photonic research into manufacturable devices.

What they specialise in

How they've shifted over time

In their first H2020 project (2018), Summa's focus was squarely on flexible microchip manufacturing — semiconductor process technology aimed at enabling new industrial markets. By 2020, their involvement had shifted toward integrated photonic and nanomaterial systems for biological applications, a pivot from general-purpose chip fabrication toward high-specificity optical sensing devices. The trajectory suggests the company is moving up the value chain: from manufacturing process enablement toward application-specific photonic products, particularly in life sciences and diagnostics.

Summa Semiconductor is moving from broad semiconductor manufacturing into the more specialised and higher-margin field of photonic biosensing, making them an increasingly relevant partner for health diagnostics, point-of-care sensing, and lab-on-chip development.

How they like to work

Summa has acted as both project coordinator and consortium participant, showing they are capable of leading smaller focused initiatives while also embedding themselves in larger research networks. Their coordination of FLEMANIE (SME Phase 1) demonstrates entrepreneurial project ownership, while joining the MSCA-RISE network IPN-Bio signals willingness to operate as a technical specialist within international academic-industrial consortia. Given their SME size, they likely contribute highly specific device or manufacturing expertise rather than broad programme management.

Summa has built connections with 13 distinct consortium partners across 8 countries within just two projects, suggesting active and varied collaboration despite their small size. Their network spans both innovation-focused SME instruments and research excellence programmes, giving them links into both academic and industrial circles.

What sets them apart

Summa Semiconductor occupies an uncommon niche as a Finnish deep-tech SME that bridges semiconductor device manufacturing and photonic biosensing — a combination rare among companies of this size. Based in Espoo, they are embedded in one of Europe's strongest hardware and electronics ecosystems, which gives them access to both industrial supply chains and academic research networks. For consortium builders, they offer the practical device-fabrication know-how that academic photonics groups typically lack.

Highlights from their portfolio

• IPN-Bio
  A long-running (2020–2025) MSCA-RISE network project integrating photonic and nano technologies for biological applications — Summa's most technically rich engagement and the clearest signal of their current strategic direction.
• FLEMANIE
  Summa's only coordinator role in H2020, a Phase 1 SME grant for flexible microchip manufacturing, demonstrating they have previously led EU-funded technology commercialisation efforts independently.